Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Baker Brothers Life Sciences Lp
Relationship:   Director
City:   New York
State:   NY
   
Insider Summary:
  
   
Companies Owned :   15    
Direct Shares   28,278,373    

Indirect Shares

   99,473,529      
Direct Value   $950,720,528    

Indirect Value

   $2,918,249,471      
Total Shares   127,751,902      
Total Value   $3,868,969,999      


Synageva BioPharma Corp $0 XOMA Corporation $336,206,558 Genomic Health Inc $576,459,614 Acadia Pharmaceuticals Inc $3,110,970 Incyte Corp $6,827,801 Alexion Pharmaceuticals Inc $24,083,248 Beigene Ltd $3,435,769 Kiniksa Pharmaceuticals, Ltd. $596,568 Synageva BioPharma Corp $0 XOMA Corporation $336,206,558 Genomic Health Inc $576,459,614 Acadia Pharmaceuticals Inc $3,110,970 Incyte Corp $6,827,801 Alexion Pharmaceuticals Inc $24,083,248 Beigene Ltd $3,435,769 Kiniksa Pharmaceuticals, Ltd. $596,568
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    13   
    1    

     Stock price went up :
    10   
    0    
     Stock price went down :
    3   
    1    
   
     Gain/Loss Ratio :
   3.3   
   -1.0   
     Percentage Gain/Loss :
   11.9%
 -16.3%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Synageva BioPharma Corp GEVA Director 2012-07-13 5,077,676 0    Premium*  
            XOMA Corporation XOMA Director 2012-07-19 13,606,093 0    Premium*  
            Genomic Health Inc GHDX Director 2012-07-26 9,086,690 0    Premium*  
            Acadia Pharmaceuticals Inc ACAD Director, 10% Owner 2023-06-01 205,752 2023-06-01 39,330,977    Premium*  
            Seagen Inc SGEN Former 10% Owner, Dire... 2023-12-14 0 2023-12-14 0    Premium*  
            Incyte Corp INCY Director, 10% Owner 2017-09-08 119,681 2017-09-08 822,826    Premium*  
            Aceragen, Inc ACGN Director 0 2014-03-10 1,613,076    Premium*  
            Alexion Pharmaceuticals Inc ALXN Director 2017-06-15 131,963 2017-06-15 1,074,556    Premium*  
            Beigene Ltd BGNE Director, 10% Owner 2023-11-14 20,838 2023-11-14 9,878,124    Premium*  
            Talis Biomedical Corp TLIS Director, 10% Owner 2021-11-18 0 2021-11-18 7,625,425    Premium*  
            Tscan Therapeutics, Inc. TCRX Director, 10% Owner 2022-05-10 0 2022-05-11 2,528,583    Premium*  
            DBV Technologies SA DBVT Director, 10% Owner 2022-06-13 0 2022-06-13 29,190,248    Premium*  
            Kiniksa Pharmaceuticals, Ltd. KNSA Director 2023-06-06 29,680 2023-06-06 2,719,343    Premium*  
            Igm Biosciences, Inc. IGMS Director 2023-06-30 0 2023-09-29 2,896,968    Premium*  
            Madrigal Pharmaceuticals Inc MDGL Director 2023-11-14 0 2023-12-14 1,793,403    Premium*  
* Premium Members only  

Records found :    114         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 1 of 5
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
BGNE Beigene Ltd Director   –       •       •   2017-10-13 4 D $0.00 $0 I/I (49,200) 0 0 -
SGEN Seagen Inc Former 10% Owner   –       •      –    2023-12-14 4 D $229.00 $2,147,483,647 I/I (44,708,503) 0 0 -
SGEN Seagen Inc Former 10% Owner   –       •      –    2023-12-14 4 D $229.00 $10,661,553 D/D (46,557) 0 0 -
BGNE Beigene Ltd Director   –       •       •   2017-10-13 4 A $0.00 $0 D/D 14,204 7,102 0 -
INCY Incyte Corp Director   –       •      –    2013-06-11 3 IO $0.00 $0 I/I 0 15,000 -
BGNE Beigene Ltd Director   –       •       •   2022-06-22 4 A $0.00 $0 I/I 66,768 67,573 0 -
ACAD Acadia Pharmaceuticals In... Director   –       •       •   2013-05-15 4 B $12.50 $24,912,500 I/I 1,993,000 389,909 2.25 -
ACAD Acadia Pharmaceuticals In... Director   –       •       •   2013-06-03 4 B $14.00 $10,794,615 I/I 767,953 406,609 2.25 -
ACAD Acadia Pharmaceuticals In... Director   –       •       •   2013-06-04 4 B $14.42 $10,110,693 I/I 699,776 421,826 2.25 -
ACAD Acadia Pharmaceuticals In... Director   –       •       •   2013-06-05 4 B $14.46 $12,657,999 I/I 872,585 440,802 2.25 -
INCY Incyte Corp Director   –       •       •   2016-12-30 4 A $100.27 $56,853 I/I 567 533,909 0 -
INCY Incyte Corp Director   –       •       •   2017-03-31 4 A $133.67 $56,943 I/I 426 767,237 0 -
INCY Incyte Corp Director   –       •       •   2017-04-27 4 OE $7.26 $435,600 I/I 60,000 787,237 0 -
INCY Incyte Corp Director   –       •       •   2017-09-08 4 B $132.00 $13,200,000 I/I 100,000 789,416 2.25 -
ALXN Alexion Pharmaceuticals I... Director   –       •      –    2017-06-15 4 B $116.54 $77,012,491 I/I 656,387 980,146 2.1 -
MDGL Madrigal Pharmaceuticals ... Director   –       •      –    2023-11-13 4 B $136.18 $10,001,368 I/I 69,839 1,465,494 2.1 %
MDGL Madrigal Pharmaceuticals ... Director   –       •      –    2023-11-14 4 B $152.21 $5,799,653 I/I 37,660 1,500,227 2.1 %
MDGL Madrigal Pharmaceuticals ... Director   –       •      –    2023-11-14 4 B $156.42 $5,347,837 I/I 34,188 1,531,757 2.1 %
MDGL Madrigal Pharmaceuticals ... Director   –       •      –    2023-11-15 4 B $161.97 $2,461,721 I/I 15,199 1,545,775 2.1 %
MDGL Madrigal Pharmaceuticals ... Director   –       •      –    2023-11-17 4 B $167.63 $8,100,704 I/I 46,370 1,588,541 2.1 %
MDGL Madrigal Pharmaceuticals ... Director   –       •      –    2023-11-20 4 B $181.93 $3,846,575 I/I 20,709 1,607,668 2.1 %
ACGN Aceragen, Inc Director   –       •      –    2014-03-10 3 IO $0.00 $0 I/I 0 1,613,076 -
MDGL Madrigal Pharmaceuticals ... Director   –       •      –    2023-11-21 4 B $183.16 $12,128,340 I/I 64,350 1,667,104 2.1 %
MDGL Madrigal Pharmaceuticals ... Director   –       •      –    2023-12-12 4 B $205.32 $7,548,616 I/I 34,578 1,699,129 2.1 %
MDGL Madrigal Pharmaceuticals ... Director   –       •      –    2023-12-13 4 B $216.70 $17,805,684 I/I 81,159 1,774,294 2.1 %
  114  Records found
  1  2   3   4   5      
  Page 1 of 5  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us